NCT04841148
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04841148
Title Avelumab or Hydroxychloroquine with or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)
Acronym PALAVY
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Abramson Cancer Center at Penn Medicine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Washington D.C. District of Columbia 20007 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
University of Washington Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field